NEOGENOMICS INC Underwriting Agreements
8 Contracts & Agreements
- Underwriting Agreement, dated January 6, 2021, among the Company and BofA Securities, Inc., Morgan Stanley & Co. LLC, and Goldman Sachs & Co. LLC, as representatives of the... (Filed With SEC on January 11, 2021)
- Underwriting Agreement, dated January (Filed With SEC on January 11, 2021)
- Underwriting Agreement, dated April 29, 2020, among the Company and Morgan Stanley & Co. LLC, BofA Securities, Inc., and SVB Leerink LLC, as representatives of the several... (Filed With SEC on May 4, 2020)
- Underwriting Agreement, dated April 29, 2020, among the Company and Morgan Stanley & Co. LLC, BofA Securities, Inc., and SVB Leerink LLC, as representatives of the several... (Filed With SEC on May 4, 2020)
- Underwriting Agreement, dated May 21, 2019, among the Company and Morgan Stanley & Co. LLC, SVB Leerink LLC and William Blair & Company, L.L.C., as representatives of the several... (Filed With SEC on May 22, 2019)
- Underwriting Agreement, dated December 11, 2018, among the Company, GE Medical Systems Information Technologies, Inc. and Morgan Stanley & Co. LLC (Filed With SEC on December 12, 2018)
- Underwriting Agreement, dated August 9, 2018, among the Company and William Blair & Company LLC and Leerink Partners LLC, as representatives of the several underwriters named... (Filed With SEC on August 10, 2018)
- NEOGENOMICS, INC. Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on August 15, 2014)
